Search Results - "Mohrschladt, M.F"

Hyperlipoproteinemia affects cytokine production in whole blood samples ex vivo. The influence of lipid-lowering therapy by Mohrschladt, M.F, Weverling-Rijnsburger, A.W.E, de Man, F.H.A.F, Stoeken, D.-J, Sturk, A, Smelt, A.H.M, Westendorp, R.G.J

“…Low-density lipoprotein (LDL)-receptor deficient mice, thus hypercholesterolemic, combine protection against infection with an ex vivo two- to threefold higher…”
Get full text

Cardiovascular disease and mortality in statin-treated patients with familial hypercholesterolemia by Mohrschladt, M.F, Westendorp, R.G.J, Gevers Leuven, J.A, Smelt, A.H.M

“…Patients with familial hypercholesterolemia (FH) are at an increased risk of premature cardiovascular disease (CVD). The benefits of statin therapy are not…”
Get full text

Modulating effect of the A-278C promoter polymorphism in the cholesterol 7alpha-hydroxylase gene on serum lipid levels in normolipidaemic and hypertriglyceridaemic individuals by HOFMAN, M. K, GROENENDIJK, M, VERKUIJLEN, Pjjh, JONKERS, Ijam, MOHRSCHLADT, M. F, SMELT, A. H. M, PRINCEN, H. M. G

“…The rate-limiting enzyme in the conversion of cholesterol into bile acids is cholesterol 7alpha-hydroxylase (CYP7A1). An A to C substitution 278 bp upstream in…”
Get full text

No effect of simvastatin treatment on C-reactive protein in patients with familial hypercholesterolemia by Mohrschladt, M.F, de Maat, M.P.M, Westendorp, R.G.J, Smelt, A.H.M

Get full text

2P-0560 TaqIB polymorphism in CETP gene: the influence on incidence of cardiovascular disease in patients with familial hypercholesterolemia by Mohrschladt, M.F., De Beer, F., Hofman, M., Van der Krabben, M., Westendorp, R.G.J., Smelt, A.H.M.

Get full text

Association of the A-278C promoter polymorphism in the cholesterol 7alpha-hydroxylase gene with hyperlipidemic disorders by Hofman, M.K., Groenendijk, M., Jonkers, I.J., Mohrschladt, M.F., Smelt, A.H., Princen, H.M.G.

Get full text